Literature DB >> 831412

Effects of vagal stimulation, atropine, and propranolol on fibrillation threshold of normal and ischemic ventricles.

M S Yoon, J Han, W W Tse, R Rogers.   

Abstract

The effects of electrical stimulation of the vagus nerves and the administration of atropine on ventricular fibrillation threshold (VFT) were studied in open-chest hearts of 15 dogs anesthetized by alpha-chloralose. These studies were made in both normal and ischemic ventricles, i.e., before and during acute coronary occlusion. The ventricles were paces at a constant rate to eliminate rate-dependent changes and the minimal current required to induce ventricular fibrillation (or VFT) was determined by delivering a train of rapid rectanglular pulses (100 per second) to the venticle actoss the vulnerable period. In normal ventricles, VFT's were significantly increased by vagal stimulation (P less than 0.01) and decreased by atropine (P less than 0.05). Coronary occlusion markedly decreased VFT's (P less than 0.01), and vagal stimulation or atropine failed to alter VFT's significantly in these ischemic ventricles (P greater than 0.8). In additional 14 dogs, the effects of vagal stimulation and atropine were studied after the administration of propranolol. Propranolol alone increased VFT's significantly in boetreatment with propranolol, vagal stimulation and atropine failed to change VFT's significantly in both normal and ischemic ventricles (P greater than 0.8). These results indicate that the vagus nerves exert their effect on VFT by modifying the sympathetic nerve activity in normal ventricles, but such an effect is not significant enough to alter VFT in ischemic ventricles.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 831412     DOI: 10.1016/s0002-8703(77)80172-5

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  16 in total

1.  Vagal nerve stimulation activates vagal afferent fibers that reduce cardiac efferent parasympathetic effects.

Authors:  Kentaro Yamakawa; Pradeep S Rajendran; Tatsuo Takamiya; Daigo Yagishita; Eileen L So; Aman Mahajan; Kalyanam Shivkumar; Marmar Vaseghi
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-09-14       Impact factor: 4.733

2.  Parasympathetic control of the spontaneous defibrillation of the heart ventricles in animals of various ages.

Authors:  V I Kobrin
Journal:  Neurosci Behav Physiol       Date:  1991 Mar-Apr

Review 3.  Vagal stimulation in heart failure.

Authors:  Gaetano M De Ferrari
Journal:  J Cardiovasc Transl Res       Date:  2014-02-06       Impact factor: 4.132

4.  Device-based autonomic modulation in arrhythmia patients: the role of vagal nerve stimulation.

Authors:  William A Huang; Kalyanam Shivkumar; Marmar Vaseghi
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-05

5.  Emotional stress and extracardiac regulation.

Authors:  L S Ul'yaninskii
Journal:  Neurosci Behav Physiol       Date:  1995 May-Jun

6.  The influence of cardiac cholinergic activation on the induction and maintenance of ventricular fibrillation.

Authors:  G Amitzur; M Manoach; M Weinstock
Journal:  Basic Res Cardiol       Date:  1984 Nov-Dec       Impact factor: 17.165

7.  Parasympathetic dysfunction and antiarrhythmic effect of vagal nerve stimulation following myocardial infarction.

Authors:  Marmar Vaseghi; Siamak Salavatian; Pradeep S Rajendran; Daigo Yagishita; William R Woodward; David Hamon; Kentaro Yamakawa; Tadanobu Irie; Beth A Habecker; Kalyanam Shivkumar
Journal:  JCI Insight       Date:  2017-08-17

Review 8.  Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions.

Authors:  Gaetano M De Ferrari; Peter J Schwartz
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

9.  Abnormal autonomic modulation of QT interval in patients with idiopathic ventricular tachycardia associated with clinically normal hearts.

Authors:  L Fei; J S Gill; D Katritsis; A J Camm
Journal:  Br Heart J       Date:  1993-04

10.  Effect of a 'vagomimetic' atropine dose on canine cardiac vagal tone and susceptibility to sudden cardiac death.

Authors:  J R Halliwill; G E Billman; D L Eckberg
Journal:  Clin Auton Res       Date:  1998-06       Impact factor: 4.435

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.